Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2010 1
2011 1
2014 1
2015 2
2016 1
2017 1
2018 2
2019 3
2020 5
2021 2
2022 4
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Results by year

Filters applied: . Clear all
Page 1
Fallopian Tube Carcinoma.
Stasenko M, Fillipova O, Tew WP. Stasenko M, et al. J Oncol Pract. 2019 Jul;15(7):375-382. doi: 10.1200/JOP.18.00662. Epub 2019 Jul 8. J Oncol Pract. 2019. PMID: 31283415 Review.
Galectins and Ovarian Cancer.
Shimada C, Xu R, Al-Alem L, Stasenko M, Spriggs DR, Rueda BR. Shimada C, et al. Among authors: stasenko m. Cancers (Basel). 2020 May 31;12(6):1421. doi: 10.3390/cancers12061421. Cancers (Basel). 2020. PMID: 32486344 Free PMC article. Review.
Disparities in cancer screenings for sexual and gender minorities.
Domogauer J, Cantor T, Quinn G, Stasenko M. Domogauer J, et al. Among authors: stasenko m. Curr Probl Cancer. 2022 Oct;46(5):100858. doi: 10.1016/j.currproblcancer.2022.100858. Epub 2022 Mar 25. Curr Probl Cancer. 2022. PMID: 35422312
SGM health curricula should be mandatory in training programs.
Cantor T, Domogauer J, Stasenko M. Cantor T, et al. Among authors: stasenko m. Curr Probl Cancer. 2023 Feb;47(1):100882. doi: 10.1016/j.currproblcancer.2022.100882. Epub 2022 Jun 23. Curr Probl Cancer. 2023. PMID: 35768317 No abstract available.
Genomic Determinants of Early Recurrences in Low-Stage, Low-Grade Endometrioid Endometrial Carcinoma.
Safdar NS, Stasenko M, Selenica P, Martin AS, da Silva EM, Sebastiao APM, Krystel-Whittemore M, Abu-Rustum NR, Reis-Filho JS, Soslow RA, Shen R, Mueller JJ, Oliva E, Weigelt B. Safdar NS, et al. Among authors: stasenko m. J Natl Cancer Inst. 2022 Nov 14;114(11):1545-1548. doi: 10.1093/jnci/djac119. J Natl Cancer Inst. 2022. PMID: 35699480 Free PMC article.
Gynecologic melanomas: A clinicopathologic and molecular analysis.
Udager AM, Frisch NK, Hong LJ, Stasenko M, Johnston CM, Liu JR, Chan MP, Harms PW, Fullen DR, Orsini A, Thomas DG, Lowe L, Patel RM. Udager AM, et al. Among authors: stasenko m. Gynecol Oncol. 2017 Nov;147(2):351-357. doi: 10.1016/j.ygyno.2017.08.023. Epub 2017 Aug 24. Gynecol Oncol. 2017. PMID: 28844540
Clinical outcomes of patients with POLE mutated endometrioid endometrial cancer.
Stasenko M, Tunnage I, Ashley CW, Rubinstein MM, Latham AJ, Da Cruz Paula A, Mueller JJ, Leitao MM Jr, Friedman CF, Makker V, Soslow RA, DeLair DF, Hyman DM, Zamarin D, Alektiar KM, Aghajanian CA, Abu-Rustum NR, Weigelt B, Cadoo KA. Stasenko M, et al. Gynecol Oncol. 2020 Jan;156(1):194-202. doi: 10.1016/j.ygyno.2019.10.028. Epub 2019 Nov 19. Gynecol Oncol. 2020. PMID: 31757464 Free PMC article.
25 results